Toru Yoshimitsu
Directeur/Bestuurslid bij OCATA THERAPEUTICS INC
Actieve functies van Toru Yoshimitsu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCATA THERAPEUTICS INC | Directeur/Bestuurslid | - | - |
Loopbaan van Toru Yoshimitsu
Eerdere bekende functies van Toru Yoshimitsu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Directeur/Bestuurslid | 01-04-2017 | 31-03-2020 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-01-2020 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 3 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Beurs
- Insiders
- Toru Yoshimitsu
- Ervaring
